# Qdenga dengue vaccine likely in India by early 2027 2026-08-10T10:07:24+00:00 | Health & Science | Indian Opinion Desk Corroboration: 1 independent outlet India's first dengue vaccine Qdenga is expected to be available in the first half of 2027, likely through private healthcare settings, infectious diseases expert Dr Chandrakant Lahariya said. The Central Drugs Standard Control Organisation granted marketing authorisation in July 2026 after evaluating safety and efficacy. Qdenga is a live, attenuated tetravalent vaccine approved for people aged 4 to 60 years. The immunisation schedule is two doses given three months apart. Takeda Pharmaceutical, the Japanese manufacturer, confirmed the timeline. The vaccine aims to protect against all four dengue virus serotypes. In 2024, India reported 232,425 dengue cases and 233 deaths, while globally the WHO recorded 14.4 million cases. Doctors say Qdenga can reduce disease severity but is unlikely to stop outbreaks on its own. ## Coverage - livemint.com Tags: dengue, India, public health, Qdenga, Takeda, vaccine Canonical: https://indianopinion.org/qdenga-dengue-vaccine-likely-in-india-by-early-2027/ License: Summary and commentary (c) Indian Opinion, reusable with attribution. Facts belong to the linked sources. Cite: https://indianopinion.org/qdenga-dengue-vaccine-likely-in-india-by-early-2027/#story-in-brief Review state: restored archive article, accurate at time of publication, not offered to search indexes.